References
Reyes J, Gayowski T, Fung J, Todo S, Alessiani M, Starzl TE (1990) Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation 50:1043–1045
Boeve BF, Kimmel DW, Aronson AE, de Groen PC (1996) Dysarthria and apraxia of speech associated with FK-506 (tacrolimus). Mayo Clin Proc 71:969–972
Bronster DJ, Gurkan A, Buchsbaum MS, Emre S (2000) Tacrolimus-associated mutism after orthotopic liver transplantation. Transplantation 70:979–982
Sokol DK, Molleston JP, Filo RS, Van Valer J, Edwards-Brown M (2003) Tacrolimus (FK506)-induced mutism after liver transplant. Pediatr Neurol 28:156–158
Sierra-Hidalgo F, Martínez-Salio A, Moreno-García S, de Pablo-Fernández E, Correas-Callero E, Ruiz-Morales J (2009) Akinetic mutism induced by tacrolimus. Clin Neuropharmacol 32:293–294
Vearrier D, Simpson SE, Greenberg MI (2011) Mutism and persistent dysarthria due to tacrolimus-based immunosuppression following allogeneic liver transplantation. Am J Ther 18:e274–e276
Toledo Perdomo K, Navarro Cabello MD, Pérez Sáez MJ, Ramos Pérez MJ, Agüera Morales ML, Aljama García P (2012) Reversible acute encephalopathy with mutism, induced by calcineurin inhibitors after renal transplantation. J Nephrol 25:839–842
Bilbao I, Dopazo C, Castells L, Lazaro J, Caralt M, Sapisochin G, Charco R (2014) Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity. Transplant Proc 46:3104–3107
Jeng KS, Chu SH, Huang CC, Lin CK, Lin CC, Chen KH (2014) Loss of speech after living-related donor liver transplantation: detection of the lesion by diffusion tensor image. Transplant Proc 46:880–882
Acknowledgments
This work was financially supported by Grant-in-Aid for Scientific Research (Grant No. 26461906), Japan Society for the Promotion of Science.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sato, K., Miura, Y., Marui, Y. et al. Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation. Int Urol Nephrol 47, 1437–1438 (2015). https://doi.org/10.1007/s11255-015-1026-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-015-1026-9